Nisa Investment Advisors
RNAC icon

Nisa Investment Advisors’s Cartesian Therapeutics RNAC Stock Holding History

Nisa Investment Advisors’s Portfolio RNAC Stock Details RNAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7K Buy
+1,600
New +$11.9K ﹤0.01% 2300
2025
Q4 		– Sell
-107
Closed -$1.09K – 3062
2025
Q3 		$1.09K Buy
107
+64
+149% +$719 ﹤0.01% 2723
2025
Q2 		$447 Sell
43
-1
-2% -$11 ﹤0.01% 2891
2025
Q1 		$580 Sell
44
-4
-8% -$71 ﹤0.01% 2767
2024
Q4 		$860 Buy
48
+37
+336% +$749 ﹤0.01% 2711
2024
Q3 		$177 Sell
11
-3
-21% -$47 ﹤0.01% 2868
2024
Q2 		$378 Buy
+14
New +$334 ﹤0.01% 2739

Other funds holding RNAC

Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nisa Investment Advisors's RNAC Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Cartesian Therapeutics (RNAC) in Q2 2026: 1,600 shares worth $16.7K. The stake represents ﹤0.01% of the portfolio and ranks #2300 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in RNAC as recently as Q3 2025.

Nisa Investment Advisors first reported a position in RNAC in Q2 2024 and has held it in 7 quarters since. 94 funds tracked by Wall St. Rank hold RNAC as of Q2 2026.

  • Nisa Investment Advisors held 1,600 shares of Cartesian Therapeutics worth $16.7K as of Q2 2026.
  • Cartesian Therapeutics was a new Nisa Investment Advisors position in Q2 2026.
  • Cartesian Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2300 holding.
  • Nisa Investment Advisors first reported a position in Cartesian Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 94 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.